The long-awaited Accelerated Access Review (AAR), proposed in 2015 and now being developed within the UK government's Industrial Strategy, was elevated back to the top of the UK health-care agenda today when health minister James O'Shaughnessy pledged an £86m ($111m) package of funding to develop four areas of activity and innovation across the UK life sciences industries. (Also see "UK Medtechs Look Beyond Brexit To Long-Term Life-Science Strategy" - Medtech Insight, 7 February, 2017.)
The Association of British Healthcare Industries (ABHI) said the funding initiatives represent an important start towards full implementation of the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?